Missing HLA C Group 1 Ligand in Patients With AML and MDS Is Associated With Reduced Risk of Relapse and Better Survival After Allogeneic Stem Cell Transplantation With Fludarabine and Treosulfan Reduced Toxicity Conditioning

American Journal of Hematology - United States
doi 10.1002/ajh.24827
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

Toxicity and Efficacy of Busulfan and Fludarabine Myeloablative Conditioning for HLA-identical Sibling Allogeneic Hematopoietic Cell Transplantation in AML and MDS

Bone Marrow Transplantation
TransplantationHematology
2016English

Survival Advantage for Patients With AML and MDS Given Allogeneic Hematopoietic STEM CELL Transplantation Using Myeloablative Versus Reduced Intensity Conditioning (RIC) MAY Become Apparent 5-10 YEARS After Transplantation

Biology of Blood and Marrow Transplantation
TransplantationHematology
2014English

Pure Red Cell Aplasia After Allogeneic Stem Cell Transplantation With Reduced Conditioning

Bone Marrow Transplantation
TransplantationHematology
2000English

Long-Term Results of Allogeneic Hematopoietic Stem Cell Transplantation After Reduced-Intensity Conditioning With Busulfan, Fludarabine, and Antithymocyte Globulin

Neoplasma
Cancer Research
2011English

Transplant Conditioning With Treosulfan/Fludarabine With or Without TBI. A Randomized Phase II Trial in Patients With MDS and AML

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Monitoring of WT1 Expression in PB and CD34+ Donor Chimerism of BM Predicts Early Relapse in AML and MDS Patients After Hematopoietic Cell Transplantation With Reduced-Intensity Conditioning

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2010English

Reduced Toxicity Conditioning With Busulfan, Fludarabine, Alemtuzumab and Allogeneic Stem Cell Transplantation From HLA-Matched Sibling Donors in Children With High Risk Sickle Cell Disease Results in Long Term Donor Chimerism and Low Incidence of aGVHD

Biology of Blood and Marrow Transplantation
TransplantationHematology
2013English

Analysis of Donor and Recipient ABO Incompatibility and Antibody-Associated Complications After Allogeneic Stem Cell Transplantation With Reduced-Intensity Conditioning

Biology of Blood and Marrow Transplantation
TransplantationHematology
2014English

GvHD-free, Relapse-Free Survival After Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation in Older Patients With Myeloid Malignancies

Bone Marrow Transplantation
TransplantationHematology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy